Observed Signal · Sep 10, 2026 · IPO · Source: Trending Topics (DACH/CEE Innovation & Tech) · Impact: 2/5 · Sentiment: Positive
Biogena lists on Vienna Stock Exchange at €485M valuation
The Austrian micronutrient manufacturer Biogena Group has listed its top holding company, BIOGENA Good Vibes AG, on the direct market plus segment of the Vienna Stock Exchange. The listing follows a digital share issuance aimed at its community, raising up to €25 million from about 2,500 new shareholders. The company's market capitalization at the start of trading was €484.8 million, with shares up 3.75%. The company plans to merge its existing listed subsidiary, Biogena Group Invest AG, into the new holding. Biogena, which had 2025 revenue of about €125 million, projects €150 million for 2026. It operates in over 70 countries, with 70% of sales from e-commerce. The company aims for medium-term revenue of €500-600 million.
The listing of a health company on a regional stock exchange segment is of limited relevance to AdTech/MarTech/Advertising; no direct advertising, marketing, or ad technology implications were mentioned.
Track Real-Time Financials Signals & Market Shifts
Polaris7 autonomous intelligence agents track regulatory filings, primary sources, executive changes, and deal flow 24/7. Create your free Explorer workspace to monitor these entities.
Key Takeaways & Evidence Grounding
- Biogena Good Vibes AG started trading on the Vienna Stock Exchange's direct market plus segment on September 10, 2026.
- Market capitalization at listing was €484.8 million.
- The company raised up to €25 million through a digital share issuance at €4.803 per share, attracting about 2,500 new shareholders.
- Biogena Group's revenue was approximately €125 million in 2025, with a projection of €150 million for 2026.
- A merger of Biogena Group Invest AG into BIOGENA Good Vibes AG is being considered.
Ontology Mapping & Concepts
Related Market Signals & Shifts
Recent verified developments and strategic activity across this market segment.
Biogena Enters Pharmacies After Non-Compete Expires
Austrian micronutrient manufacturer Biogena has launched its products in pharmacies across Austria, Germany, and Italy as of early October. The move follows the expiration of a five-year non-compete agreement tied to the 2019 sale of its pharmacy brand Nicapur. CEO Albert Schmidbauer cited the channel's complexity as a reason for the delay. The full product range of over 400 items is available in Austria and Germany, with a selected range in Italy. Biogena plans to leverage its training academy to educate pharmacy staff and increase brand awareness, particularly in Germany where it lags at under 10% versus 42% in Austria. The company recently IPO'd on the Vienna Stock Exchange with a valuation of €485 million, and its market cap has since risen to €593.9 million.
Excellent portfolio performance leads to a 7.5% increase in Net Asset Value to EUR 57.2 per share
Gimv reports a 7.5% increase in Net Asset Value to EUR 57.2 per share, driven by excellent portfolio performance. Additionally, portfolio companies Biotalys secured product registration in California for EVOCA®, and Onera's STS 2 falls within the scope of the EU MDR certificate.
BioInnovation Institute Awards €7.8M to Six Biotech Companies
BioInnovation Institute (BII) has allocated €7.8 million in additional funding to six companies developing technologies in healthcare, agriculture, and sustainable energy. Each company will receive €1.3 million, bringing their total funding from BII to €1.8 million each. The recipients include PanTarg, 3Sonic, Inia Biosciences, Yngvi Bio, Proxi Biotech, and Sagava, all working on innovations such as cancer treatments, AI-powered ultrasound, inflammatory disease therapies, biological pest control, vaccine-based immunotherapies, and waste-to-energy technology. The funding will support further development, commercialization, and attraction of external capital, with continued access to BII's Copenhagen innovation platform including labs, investor networks, and business development expertise.
Track Real-Time Market Signals & Shifts
Set up custom watchlists to receive automated, evidence-grounded executive digests whenever material signals or shifts occur across your tracked landscape.